chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Increased Fasting Glucose Levels; Initial Report Received on 12-Dec-2019  A Nurse Practitioner called and reported that a male patient who received Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) and HEPLISAV-B had elevated fasting glucose after having received HEPLISAV-B.  Medical history included liver transplant and diabetes.    Concomitant medication information was not specified.   On 02-Dec-2019, the patient received Ixiaro.    On 04-Dec-2019, the patient received a dose of HEPLISAV-B (Lot # 93383917210228, expiration 28-Feb-2021) from a pre-filled syringe.    On 11-Dec-2019, 8 days after having received HEPLISAV-B, the patient called the Nurse Practitioner and reported that he noticed that his fasting glucose levels went up to 141 from 90-96 (units, dates not specified).  The patient reported that he thinks his fasting glucose levels are up due to the HEPLISAV-B but the health care provider thinks that the other factors can cause it as well.  No additional information was provided.    Company comment: The company assessed the event of increased fasting glucose levels as non-serious. The event of increased fasting glucose levels is unlisted per HEPLISAV-B USPI.; Sender's Comments: The company assessed the event of increased fasting glucose levels as non-serious. The event of increased fasting glucose levels is unlisted per HEPLISAV-B USPI and IB.
discomfort and at times hot to the touch at the injection site 6 days after shot. I also had a very uncomfortable neck discomfort all around and right at the base of the neck and skull almost felt swollen that last a few days
The evening of the vaccination I came down with high fever of 103 and remained ill for 3 days total with temperature not falling below 101.6.  (3/31/2021 - 4/3/2021). Other symptoms included severe body aches, chills, headache.  Treatment included ibuprofen and rest. Since this reaction I have continued to have severe muscle pain/weakness in both thighs, occasionally my lower legs and upper arms which intensifies when tired or engaged in strenuous activity such as climbing stairs, cutting grass.  Prior to this event I have never had any of these symptoms unless I was ill.  I also have low grade headaches which seem to be waining but continues more than before.  Extreme fatigue and frequent tripping or falling usually a result of the muscle pain or weakness.  (Burning sensation)
12:30 AM Sunday August 1 woke up with tingling and heart beating fast.  Took blood pressure 117/85 and heart rate was 86.  Also noticed right arm where injection occurred, has swollen lymph node.  After 2 hours, at 2:30 AM Sunday August 1 heart rate went down to 68.
patient received janssen on 5/4/21 however on the consent form on 8/15/21 reported that he has not received any covid shot in the past. The consent form was processed after the patient received the Pfizer shot and was rejected by insurance because he had already received janssen.
Pt did not convert p/a series of 3 Engerix-B vax on 11OCT90, 11NOV90, & 11APR91, respectively; each inject recvd was 1 adult dose; pt was instructed that 2 more injects, 1 mo apart are needed;
7 year old female received Moderna Vaccine in error Pt did not have any adverse reaction.
10/20/15 Vaccine administered in the PM. 10/31/15: Around 8-9AM when pt woke up, she had a tender red area "the size of a baseball" at the vaccinated area. 11/1/15: Redness was widened to 5"x4".
5 minutes after receiving vaccine patient started complaining of tingling to her left arm that radiated to the face, monitored in nurse treatment room, vitals stable 118/70, HR 81, O2 sat 99% on room air. Symptoms resolved in about 8 minutes then tingling returned to the left arm, face and chest and patient reports she felt "heavy." Dr. ordered benadryl 50mg IM and was given. Patient went home with husband after being monitored for 1.5 hours after injection given and tingling resolved, patient reported she felt better.
PATIENT CALLED PHARMACY REGARDIND ADVERSE REACTION. HE STARTED FEELING "ODD" AFTER ABOUT 1 and 1/2 HOURS OF VACCINATIONS. HE WAS AT WORK AND FELT DIZZY AND "CLAMMY" AT AROUND 2 PM, ASKED BOSS FOR DAY OFF. PATIENT WENT HOME AND LAID ON BATHROOM FLOOR ABOUT 4 HRS AFTER VACCINATIONS, VOMITED AT AROUND 3:30 PM, STILL FEELING DIZZY BUT SYMPTOMS WERE NOT GETTING WORSE. FELT BETTER AND AT 9 PM WENT OUT TO BUY GATORADE FOR FLUIDS AND A COUPLE OF COOKIES, COULDN'T EAT OR DIDN'T FEEL LIKE EATING ANYTHING. PATIENT ALSO VOMITED AT AROUND 10:30 PM (LAST VOMIT). PATIENT IS FEELING A LOT BETTER TODAY (DAY AFTER VACCINES), ABOUT 80% BETTER PER PATIENT. NO PHYSICAL REACTION ON SKIN WHERE SHOTS WERE GIVEN. THE DIZZINESS ALSO WENT AWAY THIS MORNING. (PER PATIENT LAST TETANUS SHOT WAS ABOUT IN 1987)
17 year old was administered Moderna 0.5 mL today 1/3/22, no adverse effects, will reach out to parent to reschedule 2nd to be Pfizer 11-17 age group on 1/28/22 for child.
Client was screened at registration, client reported to registration staff that he was here for his first dose of Pfizer. Client was sent to vaccine station where vaccine was given to left arm without incident. Client then was sent to observation for 15 mins. While in observation and receiving education from nurse in observation unit about importance of completing series, client disclosed this was his booster. Nurse asked him to verify and he showed her immunization record from (Privacy) which showed 1st dose of Astra Zeneca was in 8/10/2021 and second dose was 10/26/2021. Nurse asked if he provided this documentation to registration staff. Client stated he did not. Vaccine card and medical record were updated to indicate booster . MD on site was consulted and informed that client was given booster dose 1 month before due date. MD spoke to client and reports ok, no need to restart . client provide information on possible adverse effect of vaccine, info given verbally and in written format.
The day after my second injection I began to feel Painful Numbness & Tingling in my hands/arms and my legs and feet. Swelling of my legs & feet, socks leaving big indents in my skin. Off and on headaches, an intense itch at times, all over, blisters on my butt(2) that "popped" and left the skin open and raw. I also just feel "off", do not feel like myself, a little bit unsure about my footing...
I am still recovering. I am super tired. I initially woke up with a light sore throat that progressed during the day. At about 4PM I noticed that I was having discomfort in the glands in my neck. About 6:00PM I was able to complete a COVID-19 home test and it was positive. By that evening I was not able to get myself into bed. I was very weak and confused by Tuesday. I slept and sweat a lot but my temperature would get up to 100.0. There were several nights where I just slept. I developed a headache that was really bad. I still have a bad headache and I am extremely tired and exhausted. I called the doctors office and had a virtual visit. I told the doctor what my oxygen was 95% and I still had a temperature. I was given anti-viral molnupiravir and I began taking it the medication on September 13, 2022. My symptoms have improved but I am still working on getting my strength back and I still have the headache.
Menstrual period started changing. Having double periods, no periods,  early and lasting longer while on birth control pills. NOW I haven?t had a period since Jan ?22. Dr said I?m too young to be in menopause
17 year old received vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received vaccine). On 23-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
inner arm(back of arm) is red two spots that look like fingers, rectangle shape by site of injection.  not hot or itchy.
2 sz in 48hr post vax prolonged >3wk h/a, anorexia, sciatica, intermittent abd pain, numbness rt side;
11/23/21 Reports 3 yo is positive for coivd and she began having a cough on Sunday, 2 days ago She did 2 test at the high school drive in and they were both positive.   Review of Systems  Constitutional: Positive for activity change, chills and fatigue. Negative for appetite change and fever.  HENT: Positive for congestion, postnasal drip, rhinorrhea, sinus pressure and sore throat. Negative for ear pain and sinus pain.   Respiratory: Positive for cough. Negative for shortness of breath and wheezing.   Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting.  Neurological: Positive for headaches.
7-9-11: Pt called to say injection site has swollen to the size of a baseball and is very hard and warm to the touch. Did not take anything or use compresses to treat it. 7-10-11: called pt for follow-up: swelling & hardness & warmth has all began to resolve and no treatment used.
Pneumovax was administered to patient on 8/13/15 at 1040.  Patient had new onset seizure on 8/14/15 at 2020 and again on 8/15/15 at 0320. Transferred to ICU, hooked up to EEG. EEG showed status epilepticus.
SWELLING ON LEFT TOE; ARM HURT A LOT; VERY TIRED; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included blood pressure abnormal, and other pre-existing medical conditions included the patient did not have any known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. Concomitant medications included lisinopril for blood pressure abnormal, and blood thinner. On 06-APR-2021, the subject experienced arm hurt a lot. On 06-APR-2021, the subject experienced very tired. On 10-APR-2021, the subject experienced swelling on left toe. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling on left toe on 11-APR-2021, and arm hurt a lot, and very tired on 07-APR-2021. This report was non-serious.; Sender's Comments: v0-Medical assessment comment is not required as per standard operating procedures.
LITTLE BIT SORE ARM; LITTLE TIRED; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.  No concomitant medications were reported. On MAR-2021, the subject experienced little bit sore arm. On MAR-2021, the subject experienced little tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the little bit sore arm and little tired was not reported. This report was non-serious.
Redness, swelling (half dollar sized) at injection site of VARIVAX vaccine 24 hours prior.
Never received second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Never received second dose) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Never received second dose). On 28-Feb-2021, PRODUCT DOSE OMISSION ISSUE (Never received second dose) had resolved. Not Provided          no treatment medications were reported concomitants medications were not reported
Approximately 10 minutes post vaccination patient reports experiencing numbness and tingling in her left arm all the way down into her fingers. Resolved after 1 hour.
sick for 2 months; Initial information received on 24-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient).  This case involves a patient of an unknown demographics who was sick for 2 months (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations and family history were not provided.   Concomitant medication was not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE [batch number and expiration date not reported] via an unknown dose, route and administration site for prophylactic vaccination.  On an unknown date, the patient was sick (illness) for 2 months, unknown latency following the administration of INFLUENZA VACCINE.  Caller reported that have not gotten 1 since and have not caught the flu. The flu shot is just a guess at what strain of the flu virus they expect for the year. Think about this they manufacture this shot at least a year before they even know what strain will develop.  No laboratory data was not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.
Per triage notes on 4/21/21: Pt had his 2nd COVID vaccine today at 0800. At 0900 developed lip swelling. Took two doses of Benadryl and has now developed chest tightness and throat swelling. Per doctor's notes: Patient is a very pleasant 60-year-old gentleman who comes in for evaluation after a possible allergic reaction today, possibly related to a second dose of Pfizer Covid vaccine that he got at 8 AM this morning.  About an hour later he started to feel flushed.  He felt like his face was warm and his ears were warm.  He started to feel like the inside of his mouth had filled with a rubber ball.  His tongue felt full and he started noticed progressively that he felt like he was having difficulty swallowing.  States that he never actually had any lip swelling, contrary to the triage note, just felt funny in the interior of his mouth.  Did feel like his tongue was slightly swollen, both based on the fact that it felt "thick" when he was talking, and on direct inspection, as well.  Took 50 mg of Benadryl around the time that his symptoms started, and lay down to nap for a little while.  When he woke up he was still feeling like he was having more difficulty swallowing.  He also felt like his face was a little bit puffy, prickly under each eye.  He also felt like he had a blotchy rash on his chest and upper back, which his wife corroborates.  He felt like his chest was a little bit tight and that something was heavy on his chest, though he was not wheezing or acutely short of breath, per se.  Took another 50 mg of Benadryl at about 2:15 PM, and presented to the emergency department for further evaluation.  Currently still has a little bit of chest tightness and throat tightness.  He feels flushed.  Symptoms have not worsened, but they have not completely resolved, either.  He has had anaphylaxis in the past and has had to be admitted to the hospital.  And this was in relation to taking doxycycline, it sounds like. Patient presented again to the ED on 4/22/21 with the same symptoms. He was admitted with anaphylaxis. Per ED notes, also diagnosed with Angioedema, improved. Likely related to second covid vaccine. Cant rule out secondary to Lisinopril.
Myalgia & Arthralgia Narrative: reports feeling fatigue, myalgias, arthralgias and h/a one day post vaccination
5 d after vacc (1/11/21) tender grape size lump at inj site.  8 d after vacc HA, fatigue, feverishness 9 d after vacc (1/15/21) large red tender area at inj site.  lump resolved.  sore L shoulder, clavicle and LUE
CHEST PAIN; SWOLLEN LYMPH NODES; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced chest pain, and swollen lymph nodes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chest pain and swollen lymph nodes was not reported. This report was non-serious.
achy; nauseated, thought he was going to throw up; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy) and NAUSEA (nauseated, thought he was going to throw up) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced MYALGIA (achy) and NAUSEA (nauseated, thought he was going to throw up). At the time of the report, MYALGIA (achy) and NAUSEA (nauseated, thought he was going to throw up) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date between 07-MAY-2018 and 10-JUL-2018, the patient was vaccinated with an improperly stored dose of VAQTA, lot # N026997, expiration date 10-NOV-2018; and ROTATEQ, lot # R002060, expiration date 05-JUN-2019 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 47 to 77 degrees (also reported as "max 55 degrees") Fahrenheit for 30 minutes and above 32 up to 35 degrees Fahrenheit for 16 hours (also reported as "brief intervals of being too cold lasting for 30 minutes each, ranging from 34 to 35.6 degrees Fahrenheit"). Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1807USA009780: US-009507513-1808USA006765: US-009507513-1808USA006766: US-009507513-1808USA006767: US-009507513-1808USA006768: US-009507513-1808USA006769: US-009507513-1808USA006770: US-009507513-1808USA006772: US-009507513-1808USA006773: US-009507513-1808USA006774: US-009507513-1808USA006775: US-009507513-1808USA006776: US-009507513-1808USA006777: US-009507513-1808USA006778.
Persistent burning/ pain in all joints, especially hips, shoulders, shoulder blades, neck. Uncomfortable to lay, sit, stand for last 48 hours and not sure how much longer I can take this.
The patient passed out about 10 seconds after receiving the vaccine.  It took her about 10 seconds to come back to.
ADMITTED TO HOSPITAL ON 9/3/2021 FOR HYPOXEMIC RESPIRATORY FAILURE WITH PROGRESSIVELY INCREASING OXYGEN REQUIREMENTS. INTUBATED ON 9/12/2021 AND DEVELOPED PNEUMOADIASTINUM. FEVER AND LEUKOCYTOSIS ON 9/18/2021.  AFTER 11 DAYS, FAMILY DISCUSSED COMFORT MEASURES DUE TO FAILURE TO IMPROVE.
Patient received Dose #1 of Monkeypox vaccine (JYNNEOS) and reported not feeling well: light-headed, dizzy, feeling of sweatiness. Team activated incident response. Patient assisted to seated position on floor with his back against the wall.  1445: BP 120/80, HR 80, RR 14, Lung Sounds Clear 1450: 130/90, HR 78, RR 14, Lung Sounds Clear, skin warm to touch, patient placed in supine position 1455: BP 124/90, HR 66, RR 14, Lung Sounds Clear, Patient sat back up to chair, given snacks and water.  Held in observation station for additional 30 minutes. Patient verbalized feeling well. Final RN assessment revealed AOX4, normal gait, no gross neurological deficit, and conversational pleasant. Counseled to watch for further adverse effects at home and to call EMS if such occurs.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 21-JUL-2017 the patient was vaccinated with ZOSTAVAX lot # M020902 expiration date 18-JUL-2017 for prophylaxis. Concomitant therapies included sterile diluent. On 21-JUL-2017, 1 day after onset of therapy the patient experienced expired product administered. On an unknown date the patient experienced no adverse event.
Headache, Myalgia, Fever, left axillary lymph swollen Narrative:
This spontaneous report was received from a physician via a company representative, and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On 09-JAN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL, lot # J009788 with expiration date of 17-MAR-2016 (strength, dose and route of administration were not reported). No concomitant medications were reported. No adverse effects and no product quality complaints were involved. On an unknown date, the vaccine was stored at a refrigerator and the reported temperature excursion lasted 176 hours, where the lowest recorded temperature was 26 F (-3.333333333 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several reports received from the same source. Additional information has been requested.
MENVEO is supplied in 2 vials that must be combined prior to administration: reconstitute the MenA lyophilized conjugate vaccine component with the MenCYW-135 liquid conjugate vaccine component immediately before administration.   The administrator only gave the liquid vial.
Hardness; A little bit swelling; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (A little bit swelling) and MYALGIA (Muscle pain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (A little bit swelling) and MYALGIA (Muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (A little bit swelling) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
He had a flushed face and bilateral arm pain/chest discomfort within minutes of injection. These symptoms resolved over a few minutes.  Patient then used left foot to push onto bed and then experienced severe lower back pain (10/10) which lasted >10 minutes so EMS was called and patient was brougt to emergency room. Pain completed resolved after 2 hours and patient was discharged home.